INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Argus II retinal prosthesis system post-market surveillance study protocol

In this page

Clinical Trial

NCT01490827 Completed
Argus II retinal prosthesis system post-market surveillance study protocol

Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01).

Interventional

Disease

Disease type

Other

Orphan drug recognition

No

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

19/12/2013

Closing date

04/09/2019

Inclusion criteria :

More

Exclusion criteria :

More

Funding

public

Members involved

Main investigators

Pr Francesco PARMEGGIANI

Representative

Italy

Low Vision Daily Life and Patients Groups (TWG5), Retinal Rare Eye Diseases (WG1)
See more

Dr Marzio CHIZZOLINI

Substitute

Italy

Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators

Center for Retinitis Pigmentosa of the Veneto Region – Camposampiero Hospital (Azienda ULSS 6 Euganea), Padova, Italy

Adress

Centro Specializzato per la Retinite Pigmentosa della Regione Veneto U.O.C. di Oculistica (Ospedale di Camposampiero, Area Rossa, 8° Piano)Via Pietro Cosma 1

35012 Camposampiero Padova

Italy